| 1 | Mesoblastic Nephroma | 46.5% |
| 2 | Nephroblastoma | 42.3% |
| 3 | Bladder Neoplasm | 29.9% |
| 4 | Ureteral Neoplasms | 29.9% |
| 5 | Urethral Neoplasms | 29.9% |
| 6 | Denys-Drash Syndrome | 25.6% |
| 7 | Anuria | 25.2% |
| 8 | Nephrolithiasis | 25.2% |
| 9 | Tuberculosis, Renal | 22.4% |
| 10 | Hydronephrosis | 20.5% |
| 11 | Hyperoxaluria | 20.5% |
| 12 | Kidney Cortex Necrosis | 20.5% |
| 13 | Kidney Papillary Necrosis | 20.5% |
| 14 | Nephritis | 20.5% |
| 15 | Nephrosclerosis | 20.5% |
| 16 | Nephrosis | 20.5% |
| 17 | Perinephritis | 20.5% |
| 18 | Kidney Failure | 20.5% |
| 19 | Uremia | 20.5% |
| 20 | Oxalosis | 20.5% |
| 21 | Renal Insufficiency | 20.5% |
| 22 | Diabetes Insipidus | 18.4% |
| 23 | Hepatorenal Syndrome | 18.4% |
| 24 | Urinary Bladder Diseases | 18.3% |
| 25 | Ureteral Diseases | 18.3% |
| 26 | Urethral Diseases | 18.3% |
| 27 | Urination Disorders | 18.3% |
| 28 | Urolithiasis | 18.3% |
| 29 | Diabetic Nephropathy | 18.3% |
| 30 | Renal hypertension | 18.3% |
| 31 | Renal Artery Obstruction | 18.3% |
| 32 | Renal Artery Stenosis | 18.3% |
| 33 | Genital Neoplasms, Male | 18.2% |
| 34 | Nephrocalcinosis | 18.2% |
| 35 | Genital Neoplasms, Female | 18.1% |
| 36 | Cystadenocarcinoma | 17.6% |
| 37 | Mucoepidermoid Carcinoma | 17.6% |
| 38 | Multicystic Dysplastic Kidney | 17.4% |
| 39 | Ureterolithiasis | 17.4% |
| 40 | Carcinoma, Lobular | 17.3% |
| 41 | Kidney Calculi | 17.2% |
| 42 | Urogenital Abnormalities | 16.8% |
| 43 | Urinary tract infection | 16.4% |
| 44 | Pyelonephritis | 16.2% |
| 45 | Carcinoma, Endometrioid | 15.9% |
| 46 | Bladder Exstrophy | 15.4% |
| 47 | Epispadias | 15.4% |
| 48 | AIDS-Associated Nephropathy | 14.9% |
| 49 | Choriocarcinoma | 14.8% |
| 50 | Adenoid Cystic Carcinoma | 14.6% |
| 51 | Adenocarcinoma, Clear Cell | 14.6% |
| 52 | Cholangiocarcinoma | 14.6% |
| 53 | Bladder neck obstruction | 14.4% |
| 54 | Basal cell carcinoma | 14.4% |
| 55 | Carcinoma, Papillary | 14.4% |
| 56 | Squamous cell carcinoma | 14.4% |
| 57 | Carcinoma, Basal Cell | 14.4% |
| 58 | Carcinoid Tumor | 14.2% |
| 59 | Pyelocystitis | 13.9% |
| 60 | Glomerulonephritis | 13.6% |
| 61 | Nephritis, Interstitial | 13.6% |
| 62 | Lipoid nephrosis | 13.6% |
| 63 | Nephrotic Syndrome | 13.6% |
| 64 | Pyelitis | 13.6% |
| 65 | Pyonephrosis | 13.6% |
| 66 | Nephrogenic Diabetes Insipidus | 13.6% |
| 67 | Congenital Nephrogenic Diabetes Insipidus | 13.6% |
| 68 | Acute kidney injury | 13.6% |
| 69 | Carcinoma, Ehrlich Tumor | 13.4% |
| 70 | Carcinoma, Lewis Lung | 13.4% |
| 71 | Ureteral Calculi | 13.3% |
| 72 | Uterine Neoplasms | 12.8% |
| 73 | Vaginal Neoplasms | 12.8% |
| 74 | Vulvar Neoplasms | 12.8% |
| 75 | Uterine Cancer | 12.8% |
| 76 | Glycosuria, Renal | 12.8% |
| 77 | Renal Osteodystrophy | 12.6% |
| 78 | Renal rickets | 12.6% |
| 79 | Urinary Bladder Fistula | 12.3% |
| 80 | Azotemia | 12.2% |
| 81 | Hypertension, Renovascular | 12.1% |
| 82 | Carcinoma, Ovarian Epithelial | 11.9% |
| 83 | Fallopian Tube Neoplasms | 11.7% |
| 84 | Penile Neoplasms | 11.7% |
| 85 | Prostatic Neoplasms | 11.7% |
| 86 | Neoplasms, Neuroepithelial | 11.4% |
| 87 | Gliomatosis cerebri | 11.4% |
| 88 | Carcinoma in Situ | 11% |
| 89 | Carcinoma, Transitional Cell | 11% |
| 90 | Carcinoma, Large Cell | 11% |
| 91 | Carcinoma, Small Cell | 11% |
| 92 | Polycystic Kidney Diseases | 11% |
| 93 | Klatskin Tumor | 10.9% |
| 94 | Carcinoma, Pancreatic Ductal | 10.9% |
| 95 | Testicular Neoplasms | 10.9% |
| 96 | Renal Aminoacidurias | 10.9% |
| 97 | Fanconi Syndrome | 10.9% |
| 98 | Pseudohypoaldosteronism | 10.9% |
| 99 | Liddle Syndrome | 10.9% |
| 100 | Hemolytic-Uremic Syndrome | 10.9% |
| 101 | Cystitis | 10.8% |
| 102 | Ureteral obstruction | 10.8% |
| 103 | Ureterocele | 10.8% |
| 104 | Urethral Obstruction | 10.8% |
| 105 | Urethritis | 10.8% |
| 106 | Vesico-Ureteral Reflux | 10.8% |
| 107 | Urinary Retention | 10.8% |
| 108 | Pregnancy Complications, Neoplastic | 10.8% |
| 109 | Malignant Carcinoid Syndrome | 10.6% |
| 110 | Adrenocortical carcinoma | 10.5% |
| 111 | Zellweger Syndrome | 10.3% |
| 112 | Infertility | 10.2% |
| 113 | Balkan Nephropathy | 10.1% |
| 114 | Focal glomerulosclerosis | 10.1% |
| 115 | Kidney Failure, Chronic | 10.1% |
| 116 | Hypospadias | 10.1% |
| 117 | Renal tubular acidosis | 9.9% |
| 118 | Bacteriuria | 9.7% |
| 119 | Glycosuria | 9.7% |
| 120 | Hematuria | 9.7% |
| 121 | Oliguria | 9.7% |
| 122 | Polyuria | 9.7% |
| 123 | Proteinuria | 9.7% |
| 124 | Pyuria | 9.7% |
| 125 | Urinary Calculi | 9.7% |
| 126 | Cystocele | 9.6% |
| 127 | Urinary Incontinence | 9.6% |
| 128 | Cystadenoma | 9.6% |
| 129 | Mesothelioma | 9.6% |
| 130 | Bowen's Disease | 9.6% |
| 131 | Urologic Diseases | 9.4% |
| 132 | Glomerulonephritis, Membranoproliferative | 9.3% |
| 133 | Adenoma | 9.2% |
| 134 | ovarian neoplasm | 9.2% |
| 135 | Horseshoe Kidney | 9.1% |
| 136 | Acanthoma | 8.8% |
| 137 | Enuresis | 8.8% |
| 138 | Trophoblastic Neoplasms | 8.7% |
| 139 | Vipoma | 8.6% |
| 140 | Gastrinoma | 8.5% |
| 141 | Glucagonoma | 8.5% |
| 142 | Endometrial Neoplasms | 8.5% |
| 143 | Genital Diseases, Male | 8.5% |
| 144 | Multiple Endocrine Neoplasia | 8.4% |
| 145 | Sexually Transmitted Diseases | 8.4% |
| 146 | Hyperphosphaturia | 8.4% |
| 147 | Abdominal Neoplasms | 8.3% |
| 148 | Head and Neck Neoplasms | 8.3% |
| 149 | leukemia | 8.3% |
| 150 | Neoplasms, Germ Cell and Embryonal | 8.3% |
| 151 | Soft Tissue Neoplasms | 8.3% |
| 152 | Thoracic Neoplasms | 8.3% |
| 153 | Germ Cell Cancer | 8.3% |
| 154 | Anti-Glomerular Basement Membrane Disease | 8.2% |
| 155 | Hermaphroditism | 8.2% |
| 156 | Disorders of Sex Development | 8.2% |
| 157 | Lupus Nephritis | 8.2% |
| 158 | Genital Herpes | 8.1% |
| 159 | Polycystic Kidney, Autosomal Dominant | 8.1% |
| 160 | Cystinuria | 8.1% |
| 161 | Atypical Hemolytic Uremic Syndrome | 8.1% |
| 162 | Neuroectodermal Tumors | 8.1% |
| 163 | Carcinoid Heart Disease | 8% |
| 164 | Hamartoma | 8% |
| 165 | Neoplasms, Hormone-Dependent | 8% |
| 166 | Neoplasms, Multiple Primary | 8% |
| 167 | Paraneoplastic Syndromes | 8% |
| 168 | Precancerous Conditions | 8% |
| 169 | Pregnancy Complications | 8% |
| 170 | Neoplasms, Second Primary | 8% |
| 171 | Meningioma | 7.7% |
| 172 | Prostatic Neoplasms, Castration-Resistant | 7.7% |
| 173 | Endometrial Stromal Sarcoma | 7.7% |
| 174 | Basal Cell Nevus Syndrome | 7.6% |
| 175 | Digestive System Neoplasms | 7.5% |
| 176 | Endocrine Gland Neoplasms | 7.5% |
| 177 | Eye Neoplasms | 7.5% |
| 178 | Nervous System Neoplasms | 7.5% |
| 179 | Medulloblastoma | 7.4% |
| 180 | Bone neoplasms | 7.4% |
| 181 | Skin Neoplasms | 7.4% |
| 182 | Hematologic Neoplasms | 7.4% |
| 183 | Histiocytic Disorders, Malignant | 7.3% |
| 184 | Splenic Neoplasms | 7.3% |
| 185 | Cervical Intraepithelial Neoplasia | 7.3% |
| 186 | Urethral Stenosis | 7.2% |
| 187 | Urethral stricture | 7.2% |
| 188 | Adenoma, Acidophil | 7.1% |
| 189 | Ganglioneuroma | 7.1% |
| 190 | Glioma | 7.1% |
| 191 | Malignant Glioma | 7.1% |
| 192 | Cyst | 7.1% |
| 193 | Neoplastic Processes | 7.1% |
| 194 | Neoplastic Syndromes, Hereditary | 7.1% |
| 195 | granulosa cell tumor | 7.1% |
| 196 | Neoplasms, Experimental | 7% |
| 197 | Paraneoplastic Encephalomyelitis | 6.9% |
| 198 | Endometriosis | 6.9% |
| 199 | Uterine Diseases | 6.9% |
| 200 | Vaginal Diseases | 6.9% |
| 201 | Vulvar Diseases | 6.9% |
| 202 | Endometrioma | 6.9% |
| 203 | Leukemia, Experimental | 6.9% |
| 204 | Mammary Neoplasms, Experimental | 6.9% |
| 205 | Carcinoma 256, Walker | 6.8% |
| 206 | Nasopharyngeal carcinoma | 6.7% |
| 207 | Parathyroid Neoplasms | 6.6% |
| 208 | Peritoneal Neoplasms | 6.6% |
| 209 | Thyroid Neoplasm | 6.6% |
| 210 | Thyroid carcinoma | 6.6% |
| 211 | Lymphoma | 6.5% |
| 212 | Retinoblastoma | 6.5% |
| 213 | Composite Lymphoma | 6.5% |
| 214 | Carcinosarcoma | 6.4% |
| 215 | Hemangiosarcoma | 6.4% |
| 216 | lymphangiosarcoma | 6.4% |
| 217 | melanoma | 6.4% |
| 218 | Albuminuria | 6.4% |
| 219 | Hemoglobinuria | 6.4% |
| 220 | Urge Incontinence | 6.4% |
| 221 | Vesicovaginal Fistula | 6.4% |
| 222 | Neoplasms, Radiation-Induced | 6.3% |
| 223 | Leukemia, Radiation-Induced | 6.2% |
| 224 | Melanoma, Experimental | 6.1% |
| 225 | Dermoid Cyst | 6.1% |
| 226 | Pancreatic Neoplasm | 6% |
| 227 | Endometritis | 6% |
| 228 | Adenofibroma | 6% |
| 229 | Fibroadenoma | 6% |
| 230 | Tuberous Sclerosis | 6% |
| 231 | Hepatocellular Adenoma | 5.8% |
| 232 | Diurnal Enuresis | 5.8% |
| 233 | Thymoma | 5.7% |
| 234 | Leukemia, Plasma Cell | 5.7% |
| 235 | Leydig Cell Tumor | 5.6% |
| 236 | Uterine Inversion | 5.6% |
| 237 | Papilloma | 5.5% |
| 238 | Pseudomyxoma Peritonei | 5.5% |
| 239 | Papillomatosis | 5.5% |
| 240 | Adenomatosis, Pulmonary | 5.5% |
| 241 | Adenomatous Polyps | 5.5% |
| 242 | Urologic Neoplasms | 5.4% |
| 243 | Dyspareunia | 5.4% |
| 244 | Corpus Luteum Cyst | 5.4% |
| 245 | Ovarian Cysts | 5.4% |
| 246 | Sarcoma, Experimental | 5.4% |
| 247 | Prolactinoma | 5.3% |
| 248 | Growth Hormone-Secreting Pituitary Adenoma | 5.3% |
| 249 | Tracheal Neoplasms | 5.2% |
| 250 | Cryptorchidism | 5.2% |
| 251 | Kidney Diseases | 5.1% |
| 252 | Uterine Rupture | 5.1% |
| 253 | Astrocytoma | 4.9% |
| 254 | Ependymoma | 4.9% |
| 255 | oligodendroglioma | 4.9% |
| 256 | Ganglioglioma | 4.9% |
| 257 | gliosarcoma | 4.9% |
| 258 | Anaplastic astrocytoma | 4.9% |
| 259 | Anaplastic Oligodendroglioma | 4.9% |
| 260 | Gonadal Dysgenesis | 4.8% |
| 261 | Kidney Neoplasm | 4.8% |
| 262 | Adrenogenital Syndrome | 4.8% |
| 263 | Ovotesticular Disorders of Sex Development | 4.8% |
| 264 | Chondrosarcoma | 4.8% |
| 265 | Craniopharyngioma | 4.8% |
| 266 | leiomyosarcoma | 4.8% |
| 267 | liposarcoma | 4.8% |
| 268 | synovial sarcoma | 4.8% |
| 269 | Neuroectodermal Tumor, Melanotic | 4.8% |
| 270 | Angiomyolipoma | 4.8% |
| 271 | Clear Cell Sarcoma of Soft Tissue | 4.8% |
| 272 | Alveolar Soft Part Sarcoma | 4.8% |
| 273 | Neuroendocrine Tumors | 4.8% |
| 274 | Sarcoma, Myeloid | 4.8% |
| 275 | Salpingitis | 4.8% |
| 276 | Vulvovaginitis | 4.8% |
| 277 | Esophageal Neoplasms | 4.7% |
| 278 | Multiple Endocrine Neoplasia Type 1 | 4.7% |
| 279 | Epididymitis | 4.6% |
| 280 | Penile Diseases | 4.6% |
| 281 | Prostatic Diseases | 4.6% |
| 282 | Spermatic Cord Torsion | 4.6% |
| 283 | Hemospermia | 4.6% |
| 284 | Testicular Hydrocele | 4.6% |
| 285 | Ameloblastoma | 4.6% |
| 286 | Angiokeratoma | 4.6% |
| 287 | Chordoma | 4.6% |
| 288 | Hemangioma | 4.6% |
| 289 | hemangiopericytoma | 4.6% |
| 290 | Lymphangioma | 4.6% |
| 291 | Mesenchymoma | 4.6% |
| 292 | Nevus | 4.6% |
| 293 | Retroperitoneal Neoplasms | 4.6% |
| 294 | Teratoma | 4.6% |
| 295 | Hepatoblastoma | 4.6% |
| 296 | Mixed Tumor, Mullerian | 4.6% |
| 297 | Germinoma | 4.6% |
| 298 | Teratocarcinoma | 4.6% |
| 299 | Angiofibroma | 4.6% |
| 300 | Sarcoma | 4.6% |
| 301 | Hyperandrogenism | 4.6% |
| 302 | Familial Hypophosphatemic Rickets | 4.5% |
| 303 | Liver Neoplasms, Experimental | 4.4% |
| 304 | Leukemia L1210 | 4.4% |
| 305 | Leukemia P388 | 4.4% |
| 306 | Adenomatous Polyposis Coli | 4.3% |
| 307 | Oophoritis | 4.3% |
| 308 | insulinoma | 4.3% |
| 309 | Neurilemmoma | 4.2% |
| 310 | Hutchinson's Melanotic Freckle | 4.2% |
| 311 | Melanoma, Amelanotic | 4.2% |
| 312 | Chorioamnionitis | 4.2% |
| 313 | Optic Nerve Glioma | 4.2% |
| 314 | Lymphomatoid Granulomatosis | 4.2% |
| 315 | Erythroplasia | 4.2% |
| 316 | Follicular cyst | 4.2% |
| 317 | Polyhydramnios | 4.2% |
| 318 | Obstetric Labor Complications | 4.2% |
| 319 | Mucocele | 4.2% |
| 320 | Pilonidal Cyst | 4.2% |
| 321 | Ectopic Pregnancy | 4.2% |
| 322 | Pregnancy, Prolonged | 4.2% |
| 323 | Puerperal Disorders | 4.2% |
| 324 | Thyroglossal Cyst | 4.2% |
| 325 | Oligohydramnios | 4.2% |
| 326 | Synovial Cyst | 4.2% |
| 327 | Prenatal Injuries | 4.2% |
| 328 | Aberrant Crypt Foci | 4.2% |
| 329 | Endometrial Hyperplasia | 4.1% |
| 330 | Pyometra | 4.1% |
| 331 | Vaginitis | 4.1% |
| 332 | Vulvitis | 4.1% |
| 333 | Vaginal Discharge | 4.1% |
| 334 | Vulvodynia | 4.1% |
| 335 | Testicular Diseases | 4.1% |
| 336 | Varicocele | 4.1% |
| 337 | Acoustic Neuroma | 4.1% |
| 338 | Mouth Neoplasms | 4.1% |
| 339 | Spermatocele | 4.1% |
| 340 | Central Nervous System Neoplasms | 4.1% |
| 341 | Vascular Neoplasms | 4.1% |
| 342 | Thymus Neoplasms | 4.1% |
| 343 | Abruptio Placentae | 4% |
| 344 | Placenta Accreta | 4% |
| 345 | Plasmacytoma | 4% |
| 346 | Malignant histiocytosis | 4% |
| 347 | Breast Neoplasms, Male | 4% |
| 348 | Histiocytic sarcoma | 4% |
| 349 | Triple Negative Breast Neoplasms | 4% |
| 350 | Fibrosarcoma | 4% |
| 351 | Osteosarcoma | 4% |
| 352 | Glioblastoma | 3.9% |
| 353 | Neuroblastoma | 3.9% |
| 354 | Glioblastoma Multiforme | 3.9% |
| 355 | Thyroid Nodule | 3.9% |
| 356 | Lymphangioleiomyomatosis | 3.8% |
| 357 | Fetal Diseases | 3.7% |
| 358 | Pregnancy Complications, Cardiovascular | 3.7% |
| 359 | Leukoplakia | 3.7% |
| 360 | Lymphocele | 3.7% |
| 361 | Pancreatic Cyst | 3.7% |
| 362 | Pregnancy Complications, Hematologic | 3.7% |
| 363 | Pregnancy Complications, Infectious | 3.7% |
| 364 | Barrett Esophagus | 3.7% |
| 365 | Breast Cyst | 3.7% |
| 366 | Fetal Death | 3.7% |
| 367 | Actinic keratosis | 3.7% |
| 368 | Mediastinal Cyst | 3.7% |
| 369 | Neoplasm Invasiveness | 3.7% |
| 370 | Neoplasm Metastasis | 3.7% |
| 371 | Neoplasm Recurrence, Local | 3.7% |
| 372 | Parovarian Cyst | 3.7% |
| 373 | Pericardial Cyst | 3.7% |
| 374 | Thymic Cyst | 3.7% |
| 375 | Carcinogenesis | 3.7% |
| 376 | Perinatal death | 3.7% |
| 377 | Myxoid cyst | 3.7% |
| 378 | Metastasis | 3.7% |
| 379 | Adrenal Gland Neoplasms | 3.6% |
| 380 | Gastrointestinal Neoplasms | 3.6% |
| 381 | Liver neoplasms | 3.6% |
| 382 | Uveal Neoplasms | 3.6% |
| 383 | Ovarian Diseases | 3.6% |
| 384 | Morning Sickness | 3.6% |
| 385 | Adnexitis | 3.6% |
| 386 | Pruritus Vulvae | 3.6% |
| 387 | Uterine hemorrhage | 3.6% |
| 388 | Vaginal Fistula | 3.6% |
| 389 | Pelvic Inflammatory Disease | 3.6% |
| 390 | Sarcoma 180 | 3.6% |
| 391 | Uterine Prolapse | 3.6% |
| 392 | Vaginal Prolapse | 3.6% |
| 393 | Puerperal Infection | 3.6% |
| 394 | Sebaceous Gland Neoplasms | 3.6% |
| 395 | Spinal Neoplasms | 3.6% |
| 396 | Bone Marrow Neoplasms | 3.6% |
| 397 | Uterine Cervical Incompetence | 3.6% |
| 398 | Malignant Fibrous Histiocytoma | 3.6% |
| 399 | Postpartum Hemorrhage | 3.6% |
| 400 | Hodgkin Disease | 3.6% |
| 401 | Lymphoma, Non-Hodgkin | 3.6% |
| 402 | Leukoplakia, Oral | 3.6% |
| 403 | Paraneoplastic Cerebellar Degeneration | 3.5% |
| 404 | Polycystic Ovary Syndrome | 3.4% |
| 405 | Turner Syndrome | 3.4% |
| 406 | Ganglioneuroblastoma | 3.3% |
| 407 | Gestational Diabetes | 3.3% |
| 408 | Primary amyloidosis | 3.2% |
| 409 | Limbic Encephalitis | 3.2% |
| 410 | Candidiasis, Vulvovaginal | 3.2% |
| 411 | Renal Cell Carcinoma | 3.2% |
| 412 | Hydatidiform Mole | 3.2% |
| 413 | Papillary Renal Cell Carcinoma | 3.2% |
| 414 | Paraganglioma | 3.2% |
| 415 | Rhabdomyosarcoma | 3.2% |
| 416 | Giant Cell Tumor of Bone | 3.2% |
| 417 | Neurofibrosarcoma | 3.2% |
| 418 | Nose Neoplasms | 3.1% |
| 419 | Lambert-Eaton Myasthenic Syndrome | 3% |
| 420 | Choledochal Cyst | 3% |
| 421 | Chlamydia Infections | 2.9% |
| 422 | Gonorrhea | 2.9% |
| 423 | Peutz-Jeghers Syndrome | 2.9% |
| 424 | Pituitary Adenoma | 2.9% |
| 425 | Pituitary Neoplasms | 2.9% |
| 426 | Dermatofibrosarcoma | 2.8% |
| 427 | Dermatofibrosarcoma Protuberans | 2.8% |
| 428 | Opsoclonus-Myoclonus Syndrome | 2.8% |
| 429 | Balanitis | 2.8% |
| 430 | Benign prostatic hypertrophy | 2.8% |
| 431 | Phimosis | 2.8% |
| 432 | Priapism | 2.8% |
| 433 | prostatitis | 2.8% |
| 434 | Prostatic Adenoma | 2.8% |
| 435 | Benign Prostatic Hyperplasia | 2.8% |
| 436 | Prostatic Hypertrophy | 2.8% |
| 437 | Prostatic Hyperplasia | 2.8% |
| 438 | Phyllodes Tumor | 2.7% |
| 439 | Dysgerminoma | 2.7% |
| 440 | Hemangioendothelioma | 2.7% |
| 441 | Lipoma | 2.7% |
| 442 | Myoma | 2.7% |
| 443 | Myxoma | 2.7% |
| 444 | Neuroma | 2.7% |
| 445 | Seminoma | 2.7% |
| 446 | Angiolipoma | 2.7% |
| 447 | Myelolipoma | 2.7% |
| 448 | Neoplasms, Bone Tissue | 2.7% |
| 449 | Neoplasms, Fibrous Tissue | 2.7% |
| 450 | Smooth Muscle Tumor | 2.7% |
| 451 | Desmoplastic Small Round Cell Tumor | 2.7% |
| 452 | Chondroma | 2.7% |
| 453 | Enchondroma | 2.7% |
| 454 | Uterine Cervicitis | 2.7% |
| 455 | Leukorrhea | 2.7% |
| 456 | Parametritis | 2.7% |
| 457 | Waldenstrom Macroglobulinemia | 2.7% |
| 458 | Multiple Myeloma | 2.7% |
| 459 | Kallmann Syndrome | 2.7% |
| 460 | Palatal Neoplasms | 2.7% |
| 461 | Syphilis | 2.7% |
| 462 | Myelitis, Transverse | 2.5% |
| 463 | Klinefelter Syndrome | 2.5% |
| 464 | Premature Ejaculation | 2.4% |
| 465 | Erectile dysfunction | 2.4% |
| 466 | Bacterial Vaginosis | 2.4% |
| 467 | Orchitis | 2.4% |
| 468 | Meningeal Neoplasms | 2.4% |
| 469 | Trichomonas Vaginitis | 2.4% |
| 470 | Uterine Perforation | 2.4% |
| 471 | Ovarian Hyperstimulation Syndrome | 2.4% |
| 472 | Leukemia, Myelomonocytic, Chronic | 2.4% |
| 473 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.4% |
| 474 | Metrorrhagia | 2.4% |
| 475 | Pheochromocytoma | 2.4% |
| 476 | Alveolar rhabdomyosarcoma | 2.4% |
| 477 | Abortion, Habitual | 2.3% |
| 478 | Dystocia | 2.3% |
| 479 | Eclampsia | 2.3% |
| 480 | Fetal Membranes, Premature Rupture | 2.3% |
| 481 | Placental Insufficiency | 2.3% |
| 482 | Pre-Eclampsia | 2.3% |
| 483 | Prenatal Exposure Delayed Effects | 2.3% |
| 484 | HELLP Syndrome | 2.3% |
| 485 | Placenta, Retained | 2.3% |
| 486 | Ear Neoplasms | 2.2% |
| 487 | Eyelid Neoplasms | 2.2% |
| 488 | Lung Neoplasms | 2.2% |
| 489 | Pleural Neoplasms | 2.2% |
| 490 | Lymphogranuloma Venereum | 2.2% |
| 491 | Mastocytosis | 2.2% |
| 492 | Sturge-Weber Syndrome | 2.2% |
| 493 | Brain Neoplasms | 2.2% |
| 494 | Salivary Gland Neoplasms | 2.2% |
| 495 | Spinal Cord Neoplasms | 2.2% |
| 496 | Tongue Neoplasms | 2.2% |
| 497 | Gastrointestinal Stromal Tumors | 2.2% |
| 498 | Hemangioma, Cavernous | 2.1% |
| 499 | Anovulation | 2.1% |
| 500 | Menorrhagia | 2.1% |
| 501 | Leukemia, T-Cell | 2.1% |
| 502 | Leukemia, B-Cell | 2.1% |
| 503 | neurofibroma | 2.1% |
| 504 | Lymphoma, Follicular | 2.1% |
| 505 | Premature Menopause | 2.1% |
| 506 | T-Cell Lymphoma | 2.1% |
| 507 | Mantle cell lymphoma | 2.1% |
| 508 | Xeroderma Pigmentosum | 2.1% |
| 509 | Neoplasms, Glandular and Epithelial | 2.1% |
| 510 | Abortion, Veterinary | 2.1% |
| 511 | Pregnancy Complications, Parasitic | 2.1% |
| 512 | Lactation Disorder | 2% |
| 513 | Mastitis | 2% |
| 514 | Pancreatic Pseudocyst | 2% |
| 515 | Depression, Postpartum | 2% |
| 516 | Embryo Loss | 2% |
| 517 | Fetal Resorption | 2% |
| 518 | Lymphatic Metastasis | 2% |
| 519 | Neoplasms, Unknown Primary | 2% |
| 520 | Leukemic Infiltration | 2% |
| 521 | Neoplasm Micrometastasis | 2% |
| 522 | Hyperemesis Gravidarum | 2% |
| 523 | Pharyngeal Neoplasms | 2% |
| 524 | Central Nervous System Cysts | 2% |
| 525 | Bile Duct Neoplasms | 1.9% |
| 526 | gallbladder neoplasm | 1.9% |
| 527 | Intestinal Neoplasms | 1.9% |
| 528 | Stomach Neoplasms | 1.9% |
| 529 | Polycythemia Vera | 1.9% |
| 530 | Azoospermia | 1.8% |
| 531 | Oligospermia | 1.8% |
| 532 | Impotence, Vasculogenic | 1.8% |
| 533 | Asthenozoospermia | 1.8% |
| 534 | Teratozoospermia | 1.8% |
| 535 | Aspermia | 1.8% |
| 536 | fibroma | 1.8% |
| 537 | Fibromatosis | 1.8% |
| 538 | Osteoblastoma | 1.8% |
| 539 | Osteoma | 1.8% |
| 540 | Rhabdomyoma | 1.8% |
| 541 | Chondromatosis | 1.8% |
| 542 | Hemangioblastoma | 1.8% |
| 543 | Lymphoma, Extranodal NK-T-Cell | 1.8% |
| 544 | Laryngeal neoplasm | 1.8% |
| 545 | Fetal Growth Retardation | 1.8% |
| 546 | Embolism, Amniotic Fluid | 1.8% |
| 547 | Fetal Hypoxia | 1.8% |
| 548 | Fetal Alcohol Spectrum Disorders | 1.8% |
| 549 | Breech Presentation | 1.8% |
| 550 | Stillbirth | 1.8% |
| 551 | Mastocytoma | 1.6% |
| 552 | Meningeal Carcinomatosis | 1.6% |
| 553 | Mastocytosis, Systemic | 1.6% |
| 554 | Leukemia, Myeloid, Chronic-Phase | 1.6% |
| 555 | Meconium Aspiration Syndrome | 1.5% |
| 556 | Bronchial Neoplasms | 1.4% |
| 557 | Multiple Pulmonary Nodules | 1.4% |
| 558 | Supratentorial Neoplasms | 1.4% |
| 559 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 560 | Leukemia, Large Granular Lymphocytic | 1.4% |
| 561 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 562 | Lymphoma, T-Cell, Cutaneous | 1.4% |
| 563 | Lymphoma, AIDS-Related | 1.4% |
| 564 | Enteropathy-Associated T-Cell Lymphoma | 1.4% |
| 565 | Primary Effusion Lymphoma | 1.4% |
| 566 | Premature Birth | 1.4% |
| 567 | Fibromatosis, Aggressive | 1.4% |
| 568 | Fibromatosis, Abdominal | 1.4% |
| 569 | Hypopharyngeal Neoplasms | 1.3% |
| 570 | Pleural Effusion, Malignant | 1.3% |
| 571 | Hypopharyngeal Cancer | 1.3% |
| 572 | Parotid Neoplasms | 1.3% |
| 573 | Nelson Syndrome | 1.3% |
| 574 | Zollinger-Ellison syndrome | 1.2% |
| 575 | Galactorrhea | 1.2% |
| 576 | Cecal Neoplasms | 1.2% |
| 577 | Duodenal Neoplasms | 1.2% |
| 578 | Burkitt Lymphoma | 1.2% |
| 579 | Carcinoma | 1.1% |
| 580 | Epithelioma | 1.1% |
| 581 | Nasopharyngeal Neoplasms | 1.1% |
| 582 | Dupuytren Contracture | 1.1% |
| 583 | Cell Transformation, Viral | 1.1% |
| 584 | Urticaria Pigmentosa | 1.1% |
| 585 | Colorectal Neoplasms | 1.1% |
| 586 | Brain Stem Neoplasms | 1.1% |
| 587 | Mycosis Fungoides | 1.1% |
| 588 | Lymphomatoid Papulosis | 1.1% |
| 589 | Plasmablastic lymphoma | 1.1% |
| 590 | Paranasal Sinus Neoplasms | 1% |
| 591 | Tonsillar Neoplasms | 1% |
| 592 | Cerebellar Neoplasms | 1% |
| 593 | Choroid Plexus Papilloma | 0.9% |
| 594 | Sezary Syndrome | 0.9% |
| 595 | Appendiceal Neoplasms | 0.9% |
| 596 | Colonic Neoplasms | 0.9% |
| 597 | Rectal Neoplasms | 0.9% |
| 598 | Hydrops Fetalis | 0.7% |
| 599 | Maxillary Sinus Neoplasms | 0.7% |
| 600 | Adenocarcinoma | 0.7% |
| 601 | Anus Neoplasms | 0.7% |
| 602 | Sigmoid Neoplasms | 0.7% |
| 603 | Radicular Cyst | 0.4% |
